Sana Biotechnology, Inc.
SANA
$1.76
-$0.01-0.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -266.76M | -305.81M | -244.90M | -308.61M | -283.26M |
| Total Depreciation and Amortization | 15.50M | 15.95M | 16.39M | 16.94M | 17.54M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.29M | 57.12M | -21.48M | 29.77M | -6.48M |
| Change in Net Operating Assets | -1.19M | 4.79M | 10.31M | 21.96M | 18.61M |
| Cash from Operations | -223.15M | -227.95M | -239.68M | -239.94M | -253.58M |
| Capital Expenditure | -33.43M | -47.04M | -45.18M | -33.70M | -20.03M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.88M | 32.72M | 40.43M | 65.76M | 192.04M |
| Cash from Investing | 17.45M | -14.33M | -4.75M | 32.06M | 172.01M |
| Total Debt Issued | 7.74M | 7.80M | 7.63M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 192.01M | 193.02M | 191.30M | 217.81M | 31.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 199.75M | 200.82M | 198.93M | 217.81M | 31.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.95M | -41.45M | -45.51M | 9.92M | -49.92M |